SSY Group Limited aims to become one of the “first echelon of pharmaceutical innovation” companies. It continuously strengthens innovation-driven development; it vigorously encourages the integration of production and research, strengthens and optimizes the five domains:new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs; and it promotes the cause of human health with strength from China!